Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis.

Kranzfelder M, Gertler R, Hapfelmeier A, Friess H, Feith M.

Surg Endosc. 2013 Oct;27(10):3530-8. doi: 10.1007/s00464-013-2991-7. Epub 2013 May 25. Review.

PMID:
23708712
2.

Thoracic duct injury during esophagectomy: 20 years experience at a tertiary care center in a developing country.

Rao DV, Chava SP, Sahni P, Chattopadhyay TK.

Dis Esophagus. 2004;17(2):141-5.

PMID:
15230727
3.

Chylothorax after esophagectomy for esophageal cancer: risk factors and management.

Gupta R, Singh H, Kalia S, Gupta R, Singh R, Verma GR.

Indian J Gastroenterol. 2015 May;34(3):240-4. doi: 10.1007/s12664-015-0571-6. Epub 2015 Jun 2.

PMID:
26027841
4.

Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.

Brinkmann S, Schroeder W, Junggeburth K, Gutschow CA, Bludau M, Hoelscher AH, Leers JM.

J Thorac Cardiovasc Surg. 2016 May;151(5):1398-404. doi: 10.1016/j.jtcvs.2016.01.030. Epub 2016 Jan 22.

PMID:
26936011
5.

A simple method minimizes chylothorax after minimally invasive esophagectomy.

Shen Y, Feng M, Khan MA, Wang H, Tan L, Wang Q.

J Am Coll Surg. 2014 Jan;218(1):108-12. doi: 10.1016/j.jamcollsurg.2013.09.014. Epub 2013 Nov 7.

PMID:
24211053
6.

Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer.

Cagol M, Ruol A, Castoro C, Alfieri R, Michieletto S, Ancona E.

World J Surg. 2009 Aug;33(8):1684-6. doi: 10.1007/s00268-009-0094-3.

PMID:
19533219
7.

Selective En Masse Ligation of the Thoracic Duct to Prevent Chyle Leak After Esophagectomy.

Lin Y, Li Z, Li G, Zhang X, Deng H, Yang X, Liu L.

Ann Thorac Surg. 2017 Jun;103(6):1802-1807. doi: 10.1016/j.athoracsur.2017.01.025. Epub 2017 Apr 3.

PMID:
28385376
8.

Isolated situs inversus of the thoracic duct, injury after esophagectomy.

Shridharani SM, Folstein MK, Yang S.

Am Surg. 2012 Mar;78(3):E132-4. No abstract available.

PMID:
22524736
9.

Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.

Takeuchi H, Saikawa Y, Oyama T, Ozawa S, Suda K, Wada N, Takahashi T, Nakamura R, Shigematsu N, Ando N, Kitajima M, Kitagawa Y.

World J Surg. 2010 Feb;34(2):277-84. doi: 10.1007/s00268-009-0331-9.

PMID:
20033687
10.

Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.

Tapias LF, Mathisen DJ, Wright CD, Wain JC, Gaissert HA, Muniappan A, Lanuti M, Donahue DM, Morse CR.

Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062. Epub 2015 Dec 1.

PMID:
26652140
11.

Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy.

Kelley ST, Coppola D, Karl RC.

J Gastrointest Surg. 2004 Mar-Apr;8(3):227-31; discussion 231-2.

PMID:
15019913
12.

[Chylothorax. An infrequent complication in surgical exeresis of the esophagus].

Faulí A, Suárez M, Castro MJ, García-Huete L, Udina E, Vilaplana J.

Rev Esp Anestesiol Reanim. 1992 Jan-Feb;39(1):43-5. Spanish.

PMID:
1598452
13.

Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.

Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M.

Eur J Surg Oncol. 2015 Jul;41(7):920-6. doi: 10.1016/j.ejso.2015.03.226. Epub 2015 Apr 8.

PMID:
25908010
14.

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).

van der Sluis PC, Ruurda JP, van der Horst S, Verhage RJ, Besselink MG, Prins MJ, Haverkamp L, Schippers C, Rinkes IH, Joore HC, Ten Kate FJ, Koffijberg H, Kroese CC, van Leeuwen MS, Lolkema MP, Reerink O, Schipper ME, Steenhagen E, Vleggaar FP, Voest EE, Siersema PD, van Hillegersberg R.

Trials. 2012 Nov 30;13:230. doi: 10.1186/1745-6215-13-230.

15.

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.

Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ.

Ann Thorac Surg. 2001 Dec;72(6):1918-24; discussion 1924-5.

PMID:
11789772
16.

Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study.

Lai FC, Chen L, Tu YR, Lin M, Li X.

Ann Thorac Surg. 2011 Jun;91(6):1770-4. doi: 10.1016/j.athoracsur.2011.02.070. Epub 2011 May 4.

PMID:
21536248
17.

Induction therapy does not increase surgical morbidity after esophagectomy for cancer.

Lin FC, Durkin AE, Ferguson MK.

Ann Thorac Surg. 2004 Nov;78(5):1783-9. Review.

PMID:
15511475
18.

A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy.

Miao L, Chen H, Xiang J, Zhang Y.

J Cancer Res Clin Oncol. 2015 May;141(5):941-50. doi: 10.1007/s00432-014-1878-x. Epub 2014 Nov 27.

PMID:
25428458
19.

Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.

Hoeppner J, Zirlik K, Brunner T, Bronsert P, Kulemann B, Sick O, Marjanovic G, Hopt UT, Makowiec F.

J Surg Oncol. 2014 Mar;109(3):287-93. doi: 10.1002/jso.23498. Epub 2013 Nov 26.

PMID:
24277235
20.

[Effect of thoracic duct ligation during transthoracic esophagectomy on the prevention of post-operative chylothorax in different tumor locations].

Lu JJ, Hou BP, Yao D, Zhang W, Qin CW, Ma J, Luo HH, Zhong FT.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Jan;11(1):36-8. Chinese.

PMID:
18197491

Supplemental Content

Support Center